SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " elevance " 108 found 🔀 AI-powered Shuffle
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
The CEOs of UnitedHealth Group, CVS Health, Elevance Health, The Cigna Group, and Ascendiun attended hearings in the House of Representatives all day Thursday.
How Recent Developments Are Shaping The Elevance Health (ELV) Investment Story
Elevance Health’s fair value estimate has been reset slightly higher to US$394.60 from US$387.16, while the discount rate remains effectively stable and revenue expectations are trimmed modestly in the model. This reflects Street research that is increasingly constructive on earnings potential in Medicare Advantage and exchanges, while still accounting for policy and utilization risks flagged in recent reports. Stay informed on these shifting inputs so you are not caught off guard as the...
3 Health Lessons Hidden In JPMorgan’s Billionaires Report
JPMorgan’s latest Principal Discussions report reveals capital management lessons with direct relevance to leaders’ health and long-term executive performance.
A Look At Elevance Health (ELV) Valuation After Recent Analyst Upgrades And Long Term Growth Optimism
Multiple analyst upgrades, led by Wolfe Research and Wells Fargo, have pushed Elevance Health (ELV) into focus as investors weigh the company’s Medicare Advantage and Medicaid exposure against expectations for earnings to bottom in 2026. See our latest analysis for Elevance Health. The recent Wolfe Research and Wells Fargo upgrades came on top of a strong run, with Elevance Health’s 30 day share price return of 13.63% and 90 day share price return of 6.09%. At the same time, the 1 year total...
Fanatics Selects Rokt to Deliver AI-Powered Relevance for Sports Fans Globally
/PRNewswire/ -- Rokt, the leading ecommerce company using machine learning and AI to make the shopping experience more relevant to each customer, today...
Taking Stock of Elevance Health (ELV)’s Valuation After Digital Health Push and Board Refresh
Elevance Health (ELV) just paired a broader rollout of its AI powered Virtual Assistant with the appointment of veteran healthcare deal maker and governance expert Amy Schulman to its board, a combination investors should parse carefully. See our latest analysis for Elevance Health. Those digital health moves and the Schulman appointment are landing against a clear shift in sentiment, with the share price up 14.3 percent over the past month but a three year total shareholder return still...
How Investors May Respond To Elevance Health (ELV) Expanding AI Assistant Access And Adding Schulman To Board
Elevance Health recently expanded access to its AI-powered Virtual Assistant for about 22 million commercial members and announced that Amy Schulman, a senior healthcare executive and governance expert, will join its board and sit on the Audit and Finance Committees in January 2026. Together, these moves highlight Elevance Health’s push to blend digital-first member support with strengthened board oversight in healthcare innovation and regulatory strategy. We’ll now examine how the broader...
Is Elevance Health, Inc.'s (NYSE:ELV) Stock's Recent Performance A Reflection Of Its Financial Health?
Elevance Health's (NYSE:ELV) stock up by 7.3% over the past three months. Given that the market rewards strong...